https://www.selleckchem.com/products/az-33.html
COVID-19 infection is the most serious global public health crisis of the century. With no approved treatments against it, investigational treatments are being used despite limited safety data. Besides being at higher risk of complications of COVID-19 infection, patients with underlying cardiovascular disease are more likely to develop cardiac-related side effects of treatment. We present a case of sinus arrest with junctional escape related to lopinavir-ritonavir. A 67-year-old man, with underlying stable ischaemic heart disease, acquire
Like
Comment
Share
